FDA Expands Approval of Leniolisib for Pediatric Patients With APDS Overview The US Food and Drug Administration (FDA) has authorized the use of leniolisib (Joenja; Pharming) for children aged 4 …
-
Association of GLP-1 Receptor Agonists With Asthma and COPD Exacerbations in Patients With Type 2 Diabetes Overview Patients with concurrent type 2 diabetes and airway diseases such as asthma or …
-
Overview of Updated ACR Guidelines The American College of Rheumatology (ACR) has revised its clinical guidance for the management of osteoarthritis (OA), updating its previous 2019 recommendations. The updated guidelines …
-
Underutilization of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Patients With Type 2 Diabetes and ASCVD Overview According to recent data published in the American Journal of Preventive Cardiology, a …
-
Here is a detailed paraphrase of the article, incorporating all original quotations and organizing the statistical data into comprehensive tables. The Resurgence of Measles: A Back-to-School Crisis in 2026 As …
-
Efficacy and Safety of AZD5462, a Novel Oral Relaxin Receptor Agonist, in Heart Failure: Findings From the Phase 2b LUMINARA Trial Importance The management of heart failure (HF) continues to …
-
Results from the phase 2b LUMINARA trial, presented at the European Society of Cardiology Congress and simultaneously published in Circulation, demonstrate that AZD5462โa novel oral relaxin receptor agonist developed by …
Evaluating the Association Between GLP-1 Receptor Agonists and Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) Overview The potential association between the use of glucagon-like peptide-1 (GLP-1) receptor agonists and the development …
Evaluation of Gabapentinoid Use and Fracture Risk in Older Adults: Findings From a Multinational Cohort Study Importance The prescribing of gabapentinoids (gabapentin and pregabalin) in older adults is common, yet …
Clinical Overview of Alexander Disease and the FDA Approval of Zanvastro Alexander disease represents an ultra-rare, progressive, and frequently fatal neurological disorder estimated to impact approximately 300 individuals across the …